AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

LIFE vs REPL: stock comparison and AI forecast

Atyr Pharma Inc (LIFE) and Replimune Group, Inc. (REPL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

LIFE Atyr Pharma Inc

Market Cap
$2.08B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

REPL Replimune Group, Inc.

Price
$20.02 +499.4% · 6M
Market Cap
$1.90B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

LIFE · REPL

Key facts

  • LIFE and REPL have similar market capitalizations ($2.08B and $1.90B).
  • REPL carries 0.83 times debt per unit of equity, against 0.44 times for LIFE.
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricLIFEREPL
Market Cap$2.08B$1.90B
P/B Ratio42.67x9.27x
EPS$-0.69$-3.02
Book Value/Share$0.76$2.16
FCF/Share$-0.86$-2.56

Profitability & Margins

MetricLIFEREPL
ROE-124.6%-132.4%
ROA-87.1%-72.5%
ROIC-109.3%-82.1%
Operating Margin-33609.5%–
Net Margin-32003.7%–
EBT Margin-31765.3%–
Tax Rate–0.2%

Financial Health

MetricLIFEREPL
Current Ratio5.12x7.11x
Quick Ratio–6.90x
D/E Ratio0.44x0.83x
Financial Leverage1.43x1.83x
Interest Coverage-837.0x-22.3x
Working Capital$47M$278M

Cash Flow

MetricLIFEREPL
Operating Cash Flow-$55M-$246M
Free Cash Flow-$55M-$243M
Capital Spending-$280K$3M

Income Statement

MetricLIFEREPL
Operating Income-$64M-$270M
Net Income-$61M-$271M
R&D Expense$47M$189M

Dividend & Shareholder Information

MetricLIFEREPL
Shares Outstanding64M95M
FAQ

LIFE vs REPL: stock comparison and AI forecast

Which is bigger, LIFE or REPL?

LIFE and REPL have similar market capitalizations ($2.08B and $1.90B).

Which one does Intratio's AI model rank higher, LIFE or REPL?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.